Search results for " STEM"

showing 10 items of 2170 documents

Congenital hepatic mesenchymal hamartoma associated with mesenchymal stem villous hyperplasia of the placenta: case report.

2005

A newborn with an unusual association of hepatic mesenchymal hamartoma and mesenchymal stem villous hyperplasia of the placenta is presented. At birth, the large hepatic mass caused severe respiratory distress necessitating early surgical intervention. This report on the association of hepatic mesenchymal hamartoma and mesenchymal stem villous hyperplasia of the placenta strongly suggests a common pathogenetic origin of the 2 lesions.

Adultcongenital hereditary and neonatal diseases and abnormalitiesPathologymedicine.medical_specialtyHepatic massHamartomaPlacentaUltrasonography PrenatalDiagnosis DifferentialMesodermPostoperative ComplicationsPregnancyPlacentamedicineEdemaHepatectomyHumansRespiratory Distress Syndrome NewbornHyperplasiaRespiratory distressbusiness.industryLiver DiseasesMesenchymal stem cellInfant NewbornGeneral MedicineHydatidiform MoleHyperplasiamedicine.diseaseJaundice Obstructivemedicine.anatomical_structureHepatic Mesenchymal Hamartomaembryonic structuresPediatrics Perinatology and Child HealthUterine NeoplasmsSurgeryFemaleChorionic VillibusinessJournal of pediatric surgery
researchProduct

Scheie syndrome: enzyme replacement therapy does not prevent progression of cervical myelopathy due to spinal cord compression.

2009

Hurler-Scheie syndrome is caused by alpha-l-iduronidase deficiency. Enzyme replacement therapy (ERT) can improve physical capacity and reduces organomegaly. However, the effect on bradytrophic connective tissue is limited. As intravenously administered enzyme cannot cross the blood-brain barrier, the therapy of choice for the more severe Hurler syndrome is haematopoietic stem cell transplantation (HCT). In the more attenuated Scheie syndrome, neurological impairment is less severe; therefore, ERT may be appropriate to treat these patients. Information on long-term outcome in Scheie patients undergoing ERT is scarce. We report a 38-year-old female Scheie patient who has been on ERT for 8 yea…

Adultcongenital hereditary and neonatal diseases and abnormalitiesmedicine.medical_specialtyMucopolysaccharidosis IMyelopathyIduronidaseSpinal cord compressionMucopolysaccharidosis IGeneticsmedicineHumansEnzyme Replacement TherapyHurler syndromeGenetics (clinical)business.industryHematopoietic Stem Cell Transplantationnutritional and metabolic diseasesBrainEnzyme replacement therapymedicine.diseaseSpinal cordSurgeryTransplantationmedicine.anatomical_structureCervical VertebraeDisease ProgressionFemaleScheie syndromebusinessSpinal Cord CompressionJournal of inherited metabolic disease
researchProduct

Early auditory evoked potentials: developmental aspects and validity in neuropaediatric and audiologic disorders.

1984

Auditory evoked potentials and in this context especially five waves in the first 10 ms (early auditory evoked potentials = EAEP) are a diagnostic aid in topodiagnosis of posterior fossa diseases. This is due to waves I to V which arise along the acoustic nerve and in brain stem structures such as medulla, pons and mid-brain. Besides an indication about the site of a lesion in the posterior fossa, wave V allows an objective threshold determination. The present results were gained in normal children aged 1-3 years and in children with neuropaediatric and audiologic disorders.

Adultmedicine.medical_specialtyAgingAdolescentPosterior fossaNeural ConductionContext (language use)AudiologyDiagnostic aidLesionChild DevelopmentMedicineHumansChildHearing DisordersMedullaNeural Conductionbusiness.industryBrain NeoplasmsInfant NewbornInfantDiffuse Cerebral Sclerosis of SchilderLeukodystrophy MetachromaticPonsChild PreschoolPediatrics Perinatology and Child HealthNormal childrenEvoked Potentials Auditorymedicine.symptomNervous System DiseasesbusinessBrain StemEuropean journal of pediatrics
researchProduct

Prognostic significance of the immunocytochemical detection of contaminating tumor cells (CTC) in apheresis products of patients with high-risk breas…

2001

The aim of this study was to determine whether the detection of CTC in the apheresis product contribute significantly to treatment failure of patients with high-risk breast carcinoma treated with high-dose chemotherapy (HDC) and stem cell transplantation (SCT). Patients were with stage II and III adenocarcinoma of the breast with > or = 10 axillary lymph nodes affected after primary surgery (> or = 10 N+) who had received HDC with SCT. We analyzed retrospectively the presence of CTC as assessed by immunocytochemistry (ICC) in the apheresis products obtained after standard adjuvant chemotherapy. We compared the clinical outcome of patients who received HDC and SCT with or without CTC-positiv…

Adultmedicine.medical_specialtyAxillary lymph nodesmedicine.medical_treatmentBreast NeoplasmsCell SeparationGastroenterologyBreast cancerRecurrenceRisk FactorsInternal medicineAntineoplastic Combined Chemotherapy ProtocolsmedicineHumansTreatment FailureSurvival rateRetrospective StudiesAnalysis of VarianceTransplantationChemotherapybusiness.industryHematopoietic Stem Cell TransplantationHematologyMiddle AgedPrognosismedicine.diseaseCombined Modality TherapyImmunohistochemistrySurgerySurvival RateTransplantationApheresismedicine.anatomical_structureBlood Component RemovalNeoplastic Stem CellsAdenocarcinomaFemaleBreast carcinomabusinessBone Marrow Transplantation
researchProduct

Features of Cytomegalovirus DNAemia Blips in Allogeneic Hematopoietic Stem Cell Transplant Recipients: Implications for Optimization of Preemptive An…

2019

Cytomegalovirus (CMV) DNAemia occurs frequently in allogeneic hematopoietic stem cell transplant recipients (allo-HSCT). There is limited information about the incidence, features, and clinical impact of CMV DNAemia blips (episodes defined by an isolated positive PCR result) in this setting. In this retrospective study, 225 consecutive adult patients undergoing any modality of allo-HSCT at our center between May 2012 and July 2019 were included. Plasma CMV DNA load was monitored using a highly sensitive real-time PCR assay. In all, 187 of 225 patients had CMV DNAemia through day 365 after allo-HSCT (total number of episodes, n = 379). Eighty-three of the 187 patients had 1 or more blips (n …

Adultmedicine.medical_specialtyCongenital cytomegalovirus infectionCytomegalovirusAntiviral Agents03 medical and health sciences0302 clinical medicineInternal medicinemedicineHumansRetrospective StudiesFirst episodeTransplantationbusiness.industryIncidence (epidemiology)Antiviral therapyHematopoietic Stem Cell Transplantationvirus diseasesRetrospective cohort studyHematologyCmv dnaemiamedicine.diseaseTransplant RecipientsHighly sensitive030220 oncology & carcinogenesisCytomegalovirus InfectionsDNA ViralAllogeneic hematopoietic stem cell transplantbusiness030215 immunologyBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
researchProduct

Early detection of embryonic malformations by transvaginal and color Doppler sonography.

1994

A total of 834 women with uneventful pregnancies were followed prospectively until the 15th week of gestation by TVS to screen for early embryonic malformations. Twenty-eight embryonic anomalies were detected in this series (3.3%). The median gestational age at diagnosis was 11 (range, 8 to 15) weeks. Two neural tube defects were missed by early TVS screening. Two suspected abdominal wall defects were not confirmed by repeat mid-second trimester abdominal sonography representing 6.7% of all fetal malformations evident by 24 weeks of gestation. The sensitivity and specificity of TVS screening for fetal malformations in this series were 93.3 and 99.7%, respectively. In addition, the role of T…

Adultmedicine.medical_specialtyDuplex ultrasonographyEarly detectionGestational AgeSensitivity and SpecificityUltrasonography PrenatalCongenital AbnormalitiesAbdominal wallPregnancyPrevalencemedicineHumansRadiology Nuclear Medicine and imagingProspective StudiesGynecologyFetusRadiological and Ultrasound Technologybusiness.industryNeural tubeGestational ageEmbryonic stem cellFetal Diseasesmedicine.anatomical_structureGestationFemalebusinessJournal of Ultrasound in Medicine
researchProduct

Estradiol counteracts oxidized LDL-induced asymmetric dimethylarginine production by cultured human endothelial cells.

2006

Objective: Asymmetric dimethylarginine (ADMA), an endogenous inhibitor of nitric oxide (NO) synthase, is a novel cardiovascular risk factor produced by endothelial cells. ADMA levels are mainly regulated by the activity of dimethylarginine dimethylaminohydrolases (DDAH). Endothelial release of ADMA is increased in the presence of oxidized LDL cholesterol (oxLDL), whereas estrogens stimulate NO production by endothelial cells by increasing both expression and activity of NO synthase and by reducing ADMA levels. Thus, the aim of the present study was to evaluate the estradiol effects on the DDAH/ADMA/NO pathway in cultured human umbilical vein endothelial cells (HUVEC) exposed to LDL. Methods…

Adultmedicine.medical_specialtyEndotheliumPhysiologymedicine.drug_classImmunoblottingGene ExpressionBiologyArginineNitric OxideUmbilical veinNitric oxideAmidohydrolaseschemistry.chemical_compoundPhysiology (medical)Internal medicinemedicineElectrochemistryHumansRNA MessengerCells CulturedChromatography High Pressure LiquidAnalysis of VarianceEstradiolReverse Transcriptase Polymerase Chain ReactionEndothelial CellsEndothelial stem cellNitric oxide synthaseLipoproteins LDLmedicine.anatomical_structureEndocrinologychemistryCell cultureEstrogenbiology.proteinEndothelium VascularNitric Oxide SynthaseCardiology and Cardiovascular MedicineAsymmetric dimethylarginineCardiovascular research
researchProduct

Bickerstaff brainstem encephalitis. A case report

1992

A 33-year-old woman three weeks after a febrile illness presented with a syndrome of ophthalmoplegia, ataxia and areflexia (SOAA) that characterizes clinically both Bickerstaff and Miller Fisher syndromes. The normality of the electrophysiological tests performed, the CSF findings and the magnetic resonance images proved that the syndrome stemmed from brainstem pathology.

Adultmedicine.medical_specialtyPathologyAtaxiaNeurologyBickerstaff brainstem encephalitisDermatologyotorhinolaryngologic diseasesmedicineHumansNeuroradiologyOphthalmoplegiaReflex Abnormalmedicine.diagnostic_testbusiness.industryGeneral NeuroscienceFebrile illnessMagnetic resonance imagingSyndromeGeneral Medicinemedicine.diseaseMagnetic Resonance ImagingPsychiatry and Mental healthEncephalitisAtaxiaFemaleNeurology (clinical)NeurosurgeryBrainstemmedicine.symptombusinessBrain StemThe Italian Journal of Neurological Sciences
researchProduct

Infections of the Central Nervous System after Unrelated Donor Umbilical Cord Blood Transplantation or Human Leukocyte Antigen–Matched Sibling Transp…

2016

We analyzed the incidence, clinical characteristics, prognostic factors, and outcome of central nervous system (CNS) infections in consecutive patients with receiving umbilical cord blood transplantation (UCBT) (n = 343) or HLA-matched sibling donor stem cell transplantation (MST) (n = 366). Thirty-four CNS infections were documented at a median time of 116 days after transplantation (range, 7 to 1161). The cumulative incidence (CI) risk of developing a CNS infection was .6% at day +30, 2.3% at day +90, and 4.9% at 5 years. The 5-year CI of CNS infection was 8.2% after UCBT and 1.7% after MST (P  .001). The causative micro-organisms of CNS infections were fungi (35%), virus (32%), Toxoplasm…

Adultmedicine.medical_specialtyTime FactorsAdolescentCentral nervous systemHuman leukocyte antigenGastroenterologyYoung Adult03 medical and health sciencesCentral Nervous System Infections0302 clinical medicineHLA AntigensInternal medicinemedicineHumansCumulative incidenceAgedTransplantationbusiness.industryUmbilical Cord Blood TransplantationIncidenceSiblingsIncidence (epidemiology)Hematopoietic Stem Cell TransplantationBacterial InfectionsHematologyMiddle Agedmedicine.diseaseTransplantationmedicine.anatomical_structureMycosesVirus DiseasesHistocompatibility030220 oncology & carcinogenesisImmunologyCord Blood Stem Cell TransplantationStem cellUnrelated DonorsbusinessToxoplasmosisEncephalitis030215 immunologyBiology of Blood and Marrow Transplantation
researchProduct

Metformin modulates human leukocyte/endothelial cell interactions and proinflammatory cytokines in polycystic ovary syndrome patients

2015

Abstract Objective We aim to assess the effect of metformin treatment on metabolic parameters, endothelial function and inflammatory markers in polycystic ovary syndrome (PCOS) subjects. Methods The study population consisted of 40 reproductive-age women with PCOS, who underwent treatment with metformin during a 12-week period, and their corresponding matched controls (n = 44). We evaluated endocrinological parameters, adhesion molecules (vascular cell adhesion molecule 1 (VCAM-1), intercellular cell adhesion molecule 1 (ICAM-1) and E-selectin) and proinflammatory cytokines (interleukin 6 (IL-6) and tumor necrosis factor alpha (TNFα)) in serum. In addition, interactions between human umbili…

Adultmedicine.medical_specialtyTime FactorsAdolescentendocrine system diseasesEndotheliumType 2 diabetesProinflammatory cytokineYoung AdultInsulin resistanceInternal medicineCell AdhesionHuman Umbilical Vein Endothelial CellsLeukocytesmedicineHumansLeukocyte RollingEndothelium Leukocyte Metformin Mitochondria PCOS Type 2 diabetesCells CulturedCell adhesion moleculebusiness.industryEndothelial Cellsnutritional and metabolic diseasesmedicine.diseasePolycystic ovaryCoculture TechniquesMetforminMetforminEndothelial stem cellTreatment Outcomemedicine.anatomical_structureEndocrinologyDiabetes Mellitus Type 2SpainCytokinesFemaleInflammation MediatorsCardiology and Cardiovascular MedicinebusinessCell Adhesion MoleculesBiomarkersPolycystic Ovary Syndromemedicine.drugAtherosclerosis
researchProduct